Myelofibrosis is the scarring of bone marrow. Symptoms include bone pain, fatigue, anemia, bruising, enlarged spleen, and low blood platelet count.
Treatment for myelofibrosis includes chemotherapy, radiation therapy, and blood transfusions. A common drug class used to treat myelofibrosis is the kinase inhibitors drug class.